3 May 2021 - Analysis of outcomes based on serum levels
Hypozincemia in the early stage of COVID-19 is associated with an increased risk of severe COVID-19
et al., Clinical Nutrition, doi:10.1016/j.clnu.2021.04.042 (Peer Reviewed)
Analysis of 240 consecutive patients in France, showing significantly higher zinc deficiency in COVID-19 patients, and significantly greater risk of hospitalization for COVID-19 patients with zinc deficiency. 2020PI087.
|
risk of hospitalization, 89.2% lower, RR 0.11, p = 0.002, high zinc levels 6 of 110 (5.5%), low zinc levels 7 of 42 (16.7%), NNT 8.9, odds ratio converted to relative risk, within COVID-19 patients.
|
|
risk of case, 27.6% lower, RR 0.72, p = 0.003, high zinc levels 110 of 188 (58.5%), low zinc levels 42 of 52 (80.8%), NNT 4.5.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. |
Fromonot et al., 5/3/2021, prospective, France, Europe, peer-reviewed, 6 authors.
Please send us
corrections, updates, or comments. Vaccines and treatments are both
valuable and complementary. All practical, effective, and safe means
should be used. Elimination of COVID-19 is a race against viral evolution. No
treatment, vaccine, or intervention is 100% available and effective for all
current and future variants. Denying the efficacy of any method increases
mortality, morbidity, collateral damage, and the risk of endemic status. We do
not provide medical advice. Before taking any medication, consult a qualified
physician who can provide personalized advice and details of risks and
benefits based on your medical history and situation. WCH
and FLCCC provide
treatment protocols.